MONDAY 27 OCTOBER
PLENARY
Dr Alastair Robertson, Deputy Chief Executive, CSIRO
Dr Benjamin P. Chen, Managing Director, Burrill & Company, San Francisco, USA
CONCURRENT SESSIONS - 11.00AM - 1.00PM
MEDTECH - Funding for Medical Technology Companies
Chair: Dr Graeme Wald, Healthcare Head of Life Sciences Research, Wilson HTM Investment Group
Professor Michael Vitale, Director, Commercialisation, Monash Asia-Pacific Centre for Science and Wealth Creation
Dr Dean Moss, General Manager, UniQuest Pty Ltd
Dr Michael Lusis, Business Director, Corporate Finance, Wilson HTM Investment Group (NOTE: PRESENTATION NOT AVAILABLE)
Mark Morrison, Chief Executive Officer, Universal Biosensors, Inc.
GLOBAL BIOTECHNOLOGY - The world's fastest growing market - Asia Pacific
Chair: Dr Ross J Horsburgh, Vice President Global Clinical Development Asia Pacific, Kendle International Inc, Singapore
Japan - Katsumi Maruyama, Director, V2V Pty Ltd
Korea - Dr Seung Ho Han, Director, Gangwon Regional Innovation Agency, South Korea
India - Dr Rashmi Barbaiya, CEO and Managing Director, Advinus Therapeutics Private Limited, India
Taiwan - Dr Ming-Chi Wu, President, Development Centre for Biotechnology, Taiwan
Singapore - Kian Teik Beh, Director Biomedical Sciences Group, Singapore Economic Development Board, Singapore
China - Professor Si Duanyun, Deputy Director, Tianjin State Key Lab of Pharmacokinetics and Pharmacodynamics, Institute of Pharmaceutical Research, China
INVESTMENT - Licensing Deals: Tips and Traps
Chair: Dr Lisa McIntyre, Regional Head of Life Sciences, L.E.K Consulting Pty Ltd
Dr Brian Bloomquist, Manager, Global External Research and Development, Eli Lilly and Company, USA
Dr Leigh Farrell, Vice President Business Development, Biota Holdings Limited
Toby Patten, Senior Associate, Baker & McKenzie
Timothy Herpin, Director, Strategic Transactions Group, Bristol-Myers Squibb, USA
CONCURRENT SESSIONS 2.00PM - 3.30PM
HUMAN HEALTH - Partnering with Big Pharma
Chair: Dr Graeme Blackman, Chairman, Institute of Drug Technology Australia Ltd
Dr Greg Wiederrecht, Vice President and Head, External Scientific Affairs, Merck & Co., Inc., USA
Dr Craig Rayner, Global Due Diligence Director, Pharma Partnering, Roche, Switzerland
Dr Glenn Begley, Vice President and Global Head of Hematology and Oncology Research, Amgen Inc, USA
BIOECONOMY - Environmental Biotechnology - Powering the Cleantech Revolution
Chair: Dr David Garman, Executive Director Environmental Biotechnology CRC & President, International Water Association
Dr Gillian Sparkes, Chief Executive Officer, Australian Sustainable Industry Research Centre
Dr Mark Bonnar, Investment Manager, Cleantech Ventures
Shaun Colley, Consultant Cleantech, eG Capital
GLOBAL BIOTECHNOLOGY - Canada - A Strategic Choice
Dr Graeme Macaloney President & CEO, QSV Biologics Ltd, Canada
INVESTMENT - Business Models that Build Value
Chair: David Blake, Co-founder & Co-editor, Bioshares
Dr Steve Gourlay, Partner, GBS Venture Partners
Denis Hanley AM, Principal, PFM Cornerstone Limited
Dr Merilyn Sleigh, Principal, InAvanti Consulting
CONCURRENT SESSIONS 4.00PM - 5.30PM
MEDTECH- Devices & Drugs - the new marriage
Chair: Clive Davenport, Chief Executive Officer, Small Technologies Cluster
Dr Joyce L. Frey-Vasconcells, Executive Director, Pharmanet Development Group, USA
Edmund O'Shaughnessy, Senior Consultant, Invetech Manufacturing Group, Invetech Pty Ltd
Dr Annie Solterbeck, Director, Statistical Revelations Pty Ltd
Dr Nina Wilkins, Director, Business Development, Acrux Ltd
GLOBAL BIOTECHNOLOGY - Manitoba: Agricultural Biotechnology - From Innovation to Commercialization
Chair: Trevor Cornell, Chief Operating Officer, Industrial Technology Centre (ITC), Manitoba, Canada
Dr Peter Jones, Director, Richardson Center for Functional Foods and Nutraceuticals, Manitoba, Canada
Garold Breit, Executive Director, University of Manitoba Technology Transfer Office, Manitoba, Canada
Lynda Lowry, General Manager & COO, Food Development Centre - a Special Operating Agency of Manitoba Agriculture, Food and Rural Initiatives, Manitoba, Canada (NOTE: PRESENTATION NOT AVAILABLE)
Sean McKay, Executive Director, Composites Innovation Centre, Manitoba, Canada
INVESTMENT- Learning from the Pioneers: An analysis of public biotech companies
Chair: David Blake, Co-founder & Co-editor, Bioshares
Graeme Kaufman, Chief Investment Officer, Strategic Life Sciences
Dr Richard Treagus, Chief Executive Officer, Acrux Ltd
Dr James Campbell, Chief Operating Officer, ChemGenex Pharmaceuticals Limited
TUESDAY 28 OCTOBER
PLENARY
Mr Alan Oster, Group Chief Economist, National Australia Bank Limited
Dr Florence Wambugu, Chief Executive Officer, Africa Harvest Biotech Foundation International, Nairobi, Kenya (to be confirmed - please email hjohnson@ausbiotech.org)
MILLIS ORATION
Dr Alan O. Trounson, President, California Institute for Regenerative Medicine, California, USA (to be confirmed - please email hjohnson@ausbiotech.org)
NATIONAL REVIEW OF AUSTRALIAN INNOVATION POLICY
CONCURRENT SESSIONS 9.00AM - 10.30AM
HUMAN HEALTH- Biosimilars: The Next Generation
Chair: Dr Timothy Oldham, President Asia Pacific, Hospira Inc.
Andrew Mitchell, Strategic Adviser, Pharmaceutical Evaluation Branch, Department of Health and Ageing, Australian Government
Dr Leonie Hunt, Director, Office of Prescription Medicine, Therapeutic Goods Administration
Professor Takao Hayakawa, Senior Advisor, Pharmaceuticals and Medical Devices Agency, Japan (NOTE: PRESENTATION NOT AVAILABLE)
Shrikumar Suryanarayan, Director General, Association of Biotechnology Led Enterprises (ABLE), India
Dr Karl Cornelius, Director, Strategic Marketing, Hospira
MEDTECH - Medical Bionics: is your Company the next Cochlear?
Chair and Introduction: Professor Robert Shepherd, Director, The Bionic Ear Institute
Professor Anthony N. Burkitt, Chair of Bio-Signals and Bio-Systems, Department of Electrical & Electronic Engineering, The University of Melbourne
Associate Professor Gregg Suaning, Centre for Implantable Bionics, University of NSW (NOTE: contact speaker directly for copy of presentation - greggs@ieee.org)
Associate Professor Peter Seligman, Senior Biomedical Engineer Cochlear Limited
Professor Stan Skafidas, National ICT Australia Limited
INVESTMENT- A blueprint for working with the United States Government - from Development to Sales
Chair: Dr Simon Carroll, Deputy Chair, AusBiotech Ltd
Claire Driscoll, Director, Technology Transfer Office, National Human Genome Research Institute, US National Institute of Health, USA
John Clerici, Partner, McKenna Long & Aldridge LLP, USA
Garry Redlich, Chief Executive Officer, Implicit Bioscience Ltd
Richard Haiduck, Chief Business Advisor, Implicit Bioscience Ltd / Cytopia
CONCURRENT SESSIONS 2.00PM - 3.30PM
MEDTECH - Accessing Global Medical Technology Supply Chains
Chair: Dr Colin Sutton, Director, Mission Pty Limited
Ben Yerbury, Associate Director Business Development & Strategic Planning ANZ, Baxter Healthcare Pty Limited
Matthew Hoskin, Director, Global Commercial Marketing, Leica Microsystems
Dr Daniel Grant, Head of Strategic Alliances Pfizer Global Pharmaceuticals, Pfizer Australia (NOTE: PRESENTATION NOT AVAILABLE)
BIOECONOMY - Bioeconomy
Chair: Cameron Begley, Business Development Manager, CSIRO Entomology
Anthony Arundel, Policy Analyst, Organisation for Economic Co-operation and Development (OECD) (NOTE: PRESENTATION NOT AVAILABLE)
Dr Trevor Stuthridge, Group Manager Sustainable Design, SCION, New Zealand (NOTE: PRESENTATION NOT AVAILABLE)
Dr Stevens Brumbley, Project Leader, Australian Institute for Bioengineering and Nanotechnology
Dr Allan Green, Program Leader of the Metabolic Engineering of New Plant Products , CSIRO Plant Industry
INVESTMENT - Value Creation Strategies
Chair: Dr John Holaday, Managing Director and CEO, QRxPharma Ltd
Dr Jackie Fairley, Chief Executive Officer, Starpharma Pty Ltd
Michael Quinn, Managing Partner, Innovation Capital Limited
Michael Spooner, Chairman, Hunter Immunology Limited
(Note: no presentations used for the above session)
GLOBAL BIOTECHNOLOGY - Recent Changes to Australian and Global Intellectual Property Legislation
Chair: Michael Gilbert, General Manager and Company Secretary, Australian Centre for Plant Functional Genomics Pty Ltd
Dr Lisa Haile, Attorney / Partner, DLA Piper, USA
Dr Andrew Blattman, Principal, Spruson & Ferguson
Ram Deshpande, Senior Manager, Evalueserve Business Consulting (Shanghai) Co., China
Dr Malathi Lakshmikumaran, Consultant, Lakshmikumaran & Sridharan, Advocates, India
CONCURRENT SESSIONS 4.00PM - 5.30PM
MEDTECH - Reimbursement: Consider it early or pay a heavy price.
Chair and introduction: Peter Taylor, Chief Executive Officer, V-Patch Medical Systems
Sue O'Malley, Principal Consultant and Founder, Medical Intelligence
Dr Evan Siegel, President & CEO, Ground Zero Pharmaceuticals, Inc., USA
Ping Poulsen, President & CEO, Safis Solutions LLC, Indiana, USA
Dr Arthur Brandwood, Principal, Brandwood Biomedical Pty Ltd
BIOECONOMY - Biomaterials
Chair: Sean McKay, Executive Director, Composites Innovation Centre, Manitoba, Canada
Professor Lars Nielsen, Group Leader, Australian Institute of Bioengineering and Nanotechnology
Leo Hyde, Research and Development Director, Australia/New Zealand and ASEAN, Dupont Australia (NOTE: PRESENTATION NOT AVAILABLE)
Dr Kishan Khemani, Chief Technology Officer, Plantic (NOTE: PRESENTATION NOT AVAILABLE)
Simon Yarrow, Chief Executive Officer, EnCoate, New Zealand
INVESTMENT - Global Investment
Chair: Simon De Young, Partner, Baker & McKenzie
Bill Guo, Chairman and Chief Executive Officer, Venturepharm Group, China
Dr Barbara Dalton, Vice President Venture Capital, Pfizer Inc, USA (NOTE: PRESENTATION NOT AVAILABLE)
Brandon Lewis, Managing Director, The Trout Group LLC, San Francisco, USA
Jeremy Curnock Cook, Executive Chairman, Bioscience Managers Limited, United Kingdom
WEDNESDAY 29 OCTOBER
CONCURRENT SESSIONS 9.00AM - 10.30AM
HUMAN HEALTH - Latest trends in Clinical Trials
Chair and speaker:
Dr Christopher H. Cabell, Chief Medical and Scientific Officer, Quintiles Transnational Corp, USA
Dr Scott Patterson, Executive Director, Medical Sciences, Amgen Inc, USA
Dr Russell Basser, Global Director of Clinical Development, CSL Limited (NOTE: PRESENTATION NOT AVAILABLE)
BIOECONOMY - Modern approaches to veterinary vaccines
Chair: Professor Ben Adler, Director, ARC Centre of Excellence in Structural and Functional Microbial Genomics
Professor Julian Rood, Department of Microbiology, Monash University (NOTE: PRESENTATION NOT AVAILABLE)
Professor Glenn Browning, Professor in Veterinary Biology, University of Melbourne
Professor Els Meeusen, Department of Physiology, Monash University
Dr James Gilkerson, Senior Lecturer in Veterinary Microbiology, University of Melbourne (NOTE: PRESENTATION NOT AVAILABLE)
INDUSTRIAL BIOTECH - Biofuels - second generation
Chair: Professor Tony Bacic, Director, Bio21 Institute, University of Melbourne
Dr Manuel Sainz, Group Leader, Syngenta Centre for Sugarcane Biofuels Development (NOTE: PRESENTATION NOT AVAILABLE)
Mr Rob Thomas, Chief Sustainable Systems, South Australia Research and Development Institute
Mr Al Bryant, General Manager, Boeing Phantom Works Australia
GLOBAL BIOTECHNOLOGY - Global Partnering Opportunities
Chair: Dr David Irving, Manager (Acting) National Research and Business Development, Australian Red Cross Blood Service
Dr Eli Opper, Chief Scientist, Ministry of Industry, Trade & Labor, Israel
Dr Sang Ki Rhee, Senior Research Fellow, Korea Research Institute of Bioscience and Biotechnology, South Korea
Dr Dianne Glenn, Principal, Corelli Consulting
Jim Murray, Chief Executive Officer, AT-Bio Pty Ltd
CONCURRENT SESSIONS 11.00AM - 12.30PM
HUMAN HEALTH - Investing in Cell Therapies in Australia - from benchtop to patient
Chair: Dr Susan Pond AM, Chairman, AusBiotech Ltd
Dr Dianne Jackson-Matthews, Director, ERA Consulting Australia
Dr Dominic Wall, Chief Scientific Officer, Cell Therapies Pty Ltd
Professor Richard Boyd, Chief Scientific Officer, Norwood Immunology (NOTE: PRESENTATION NOT AVAILABLE)
BIOECONOMY - Nutraceuticals and Functional Foods
Chair: Mr Peter Hobman, General Manager, MG Nutritionals
Dr Michael Fenech, Theme Leader: Nutrigenomics and Nutrigenetics - Personalised Nutrition for Health Genes and Minds, CSIRO Human Nutrition, Food Science Australia
Professor Linda Tapsell, Director, Smart Foods Centre, University of Wollongong (NOTE: PRESENTATION NOT AVAILABLE)
Professor Stephen Myers, Head NatMed Research Unit, Southern Cross University
Dr Calvin London, CEO / Managing Director, Stirling Products Limited (NOTE: PRESENTATION NOT AVAILABLE)
INDUSTRIAL BIOTECH - Industrial Biotech
Chair: Mr Craig Pennifold, Head of Innovation Division, Department of Innovation, Industry, Science and Research, Australian Government
Damien Perriman, Business Leader, Bioscience, The Dow Chemical Company, USA
Dr Douglas Hawkins, Program Manager, Green Chemistry, Rohm and Haas Company, USA (NOTE: PRESENTATION NOT AVAILABLE)
Dr Stephen Meller, Head of Global Biosciences Business Development The Procter & Gamble Company, USA
Ed Lehrburger, President, PureVision Technology Inc., USA (NOTE: PRESENTATION NOT AVAILABLE)
Latest News & Press Releases